Viewing Study NCT03904069


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-03-04 @ 12:02 PM
Study NCT ID: NCT03904069
Status: WITHDRAWN
Last Update Posted: 2023-06-12
First Post: 2019-03-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed/refractory acute myeloid leukemia View
None Acute myeloid leukemia View
None Oncology/hematology View
None CAR T cell therapy View